Skip to content

Author

A. Eriksson

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Initial Changes in eGFR during Treatment with Balcinrenone and Dapagliflozin: An Exploratory Analysis of the MIRO-CKD Trial.

INTRODUCTION The novel non-steroidal mineralocorticoid receptor antagonist balcinrenone in combination with dapagliflozin reduced urinary albumin-to-creatinine ratio (UACR) over 12 weeks in the MIRO-CKD phase 2 trial in chronic kidney disease (CKD) and induced a modest acute eGFR reduction upon treatment initiation. Th...

H. Heerspink, Erika de Sousa Amorim, Jelle M. Beernink et al. · 0 citations
Clinical trial Open access Sep 2026

Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics and the Pharmacokinetics of Balcinrenone When Dosed with a P‐gp Inhibitor

Dosing of balcinrenone/dapagliflozin without regard to food supports dosing of balcinrenone/dapagliflozin without regard to food, and balcinrenone is not considered a sensitive P‐gp substrate.

A. Eriksson, D. Karsanji, Amy H. Shi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.